DOX-TCO
Doxorubicin-TCO
Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
---|---|---|---|---|
R-M2-9621 | 25mg | 696.00 | + Add to cart |
|
R-M2-9621 | 50mg | 1189.00 | + Add to cart |
|
|
Product description
DOX-TCO,Doxorubicin-TCO can design drug delivery systems that enable the drug to be selectively activated or released at tumor sites. This helps reduce systemic toxicity and improve therapeutic efficacy.
The TCO moiety allows for bioorthogonal reactions, where the doxorubicin can be selectively released or activated in the presence of specific partners (like tetrazines) within biological systems. This enables very precise timing and location of drug action.
Doxorubicin-TCO conjugates are part of ongoing research aimed at improving the delivery methods of chemotherapeutic agents.
The TCO moiety allows for bioorthogonal reactions, where the doxorubicin can be selectively released or activated in the presence of specific partners (like tetrazines) within biological systems. This enables very precise timing and location of drug action.
Doxorubicin-TCO conjugates are part of ongoing research aimed at improving the delivery methods of chemotherapeutic agents.

Appearance | N/A |
---|---|
Molecular weight | N/A |
Solubility | N/A |
Molecular formula | N/A |
Storage | -20℃, protected from light and moisture |
Transportation | 4-25℃ temperature for up to 3 weeks |
Stability | 1 year |
Document
Related Product